Brief: Camurus Gets EMA Acceptance Of MAA Filing For Octreotide SC Depot
May 23 (Reuters) - Camurus AB CAMX.ST :
* CAMURUS RECEIVES EMA ACCEPTANCE OF MAA FILING FOR
OCTREOTIDE SC
DEPOT (CAM2029) FOR THE TREATMENT OF ACROMEGALY
Source text for Eikon: ID:nWkrJzNZ6
Further company coverage: CAMX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Camurus AB
See all newsBrief: Camurus Receives Approval In Canada For Oczyesa XR
Brief: Executive Sells About £279,000 Of Camurus Shares
Jefferies cuts Ipsen to 'underperform' on Somatuline competition risk
Brief: Camurus Says NDA Resubmission For CAM2029 In Acromegaly Accepted For Review By FDA
Camurus shares rise after Q2 revenue, operating profit beat